SCHEMBL8636613

SCHEMBL8636613

COc1cc(/C=C/C(=O)Nc2c(O)cccc2C(N)=O)cc(OC)c1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.59
HPGD P15428 4/20 0.59
KDM4E B2RXH2 4/20 0.59
LMNA P02545 3/20 0.59
GAA P10253 2/20 0.59
NPSR1 Q6W5P4 1/20 0.59
MAPT P10636 2/20 0.59
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA9 Q16790 1/20 0.56
HTT P42858 2/20 0.55
SMN1; SMN2 Q16637 3/20 0.54
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
BCHE P06276 2/20 0.53
ABCG2 Q9UNQ0 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C19 P33261 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8636635 1.00 ALDH1A1 (0.59) ALDH1A1HPGDKDM4ELMNAGAA
SCHEMBL14801992 0.90 ALDH1A1 (0.60) ALDH1A1HPGDKDM4ELMNAGAA
SCHEMBL20537714 0.84 HTT (0.57) ALDH1A1HPGDKDM4ELMNAGAA
SCHEMBL20537712 0.84 HTT (0.57) ALDH1A1HPGDKDM4ELMNAGAA
SCHEMBL8635335 0.83 ALDH1A1 (0.80) ALDH1A1HPGDKDM4ELMNAGAA
SCHEMBL8635343 0.83 ALDH1A1 (0.80) ALDH1A1HPGDKDM4ELMNAGAA
SCHEMBL8641782 0.82 ALDH1A1 (0.65) ALDH1A1HPGDKDM4ELMNAGAA
SCHEMBL8641773 0.82 ALDH1A1 (0.65) ALDH1A1HPGDKDM4ELMNAGAA
SCHEMBL20537896 0.82 BCHE (0.58) ALDH1A1HPGDKDM4ELMNAMAPT
SCHEMBL19800966 0.82 BCHE (0.58) ALDH1A1HPGDKDM4ELMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0855387-A1 2-ACYLAMINOBENZAMIDE DERIVATIVES AND PREVENTIVE AND REMEDY FOR DISEASES CAUSED BY THE SUPERMULTIPLICATION OF VASCULAR INTIMAL CELLS KISSEI PHARMACEUTICAL CO., LTD. (JP) 1998-07-29 EP disclosed